BRUSSELS, July 31 (Reuters) - The European Union's executive
on Friday wrapped up talks with French drugmaker Sanofi
aimed at securing its COVID-19 vaccine for the
27-country EU bloc.
"The envisaged contract with Sanofi would provide for an
option for all EU Member States to purchase the vaccine," the
European Commission said in a statement.
"It is envisaged that, once a vaccine has proven to be safe
and effective against COVID-19, the Commission would have a
contractual framework in place for the purchase of 300 million
doses, on behalf of all EU member states."
Sanofi is working on two vaccine projects including one in
partnership with GlaxoSmithKline.
(Reporting by Foo Yun Chee;
Editing by Andrew Cawthorne)
Glaxosmithkline (GSK)